4.6 Review

Advances of blood cell-based drug delivery systems

Journal

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 96, Issue -, Pages 115-128

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejps.2016.07.021

Keywords

Blood cell; Erythrocytes; Leukocytes; Platelets; Drug delivery systems

Funding

  1. National Natural Science Foundation of China [81977757]
  2. Morning Star Plan of SJTU [AF1700016]

Ask authors/readers for more resources

Blood cells, including erythrocytes, leukocytes and platelets are used as drug carriers in a wide range of applications. They have many unique advantages such as long life-span in circulation (especially erythrocytes), target release capacities (especially platelets), and natural adhesive properties (leukocytes and platelets). These properties make blood cell based delivery systems, as well as their membrane-derived carriers, far superior to other drug delivery systems. Despite the advantages, the further development of blood cell-based delivery systems was hindered by limitations in the source, storage, and mass production. To overcome these problems, synthetic biomaterials that mimic blood cell and nanocrystallization of blood cells have been developed and may represent the future direction for blood cell membrane-based delivery systems. In this paper, we review recent progress of the rising blood cell-based drug delivery systems, and also discuss their challenges and future tendency of development. (C) 2016 Published by Elsevier B.V.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available